
News|Videos|December 9, 2015
Role of Platelet Aggregation Inhibitors in ACS Management
Katie Greenlee, PharmD, BCPS-AQ Cardiology, of the Cleveland Clinic discusses the role of platelet aggregation inhibitors in ACS management.
Advertisement
Katie Greenlee, PharmD, BCPS-AQ Cardiology, of the Cleveland Clinic discusses the role of platelet aggregation inhibitors in ACS management.
This video was recorded at the 2015 American Society of Health-System Pharmacists Midyear Meeting.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Denosumab Biosimilars, Osvyrti and Jubereq, for Reference Products’ Indications
2
CDC’s Autism Statement Sparks New Concerns Over Vaccine Safety Messaging
3
Patients With Long COVID Face Varying Trajectories, With Most Facing Symptoms Long After Infection
4
Billions at Stake: 340B Program Integrity and Sustainability in 2024–2025
5












































































































































































































